A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Clinical trial NCT05608681 · RECRUITING

Trial details

NCT number: NCT05608681
Sponsor: Eupraxia Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2023-03-31
Primary completion: 2026-12-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.